Home Business

Ashok Leyland gains on Dec sales jump

Ashok Leyland ended the day at Rs 53, higher by Rs 0.6 or 1.2%. The counter saw total trades of over 10.99 lakh shares on the BSE as against he two-week average of 13.20 lakh shares. Jan cement sales in high double-digit --------------------------------------------------------------------------------------------------------(Updated at 0928 am) Ashok Leyland has gained in morning trades on a jump in December net sales. The stock opend at Rs 54 and jumped to a high of Rs 54.80 - up 4%. It is now trading with a gain of 2% at Rs 53.85. The counter has seen trades of over 3.48 lakh shares on the BSE. The company"s net sales for the month of December has zoomed 164%, compared to the same period a year ago. The company sold 6,099 units in December 2009 compared to 2,307 units in the same month of the previous year, an increase of 164%. However, the company"s exports dipped to 563 units as against 901 units in December 2008.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
Govt approval on price mandatory: RIL to SC
Hearing in the gas row between the Ambani brothers entered the final phase in the Supreme Court today with Mukesh Ambani Group Reliance Industries (RIL) asserting that government approval on gas pricing is mandatory, a contention opposed by the Anil Ambani-led Reliance Natural Resources (RNRL).
Popular Articles

Govt imposes stock limit on bulk sugar consumers
The government today imposed stock limit on bulk sugar consumers, allowing them to keep quantities sufficient for only 15 days of their consumption at any point of time. The stock limit would be in force for six months and would be applicable to consumers whose monthly sugar consumption is at least one tonne, the government said in a statement. The move will affect confectioneries, large biscuit and beverage producing units.

Sun, Caraco to file 30 marketing applications for generics
Sun Pharmaceutical Industries and its troubled US subsidiary, Caraco Pharmaceuticals, plan to together file 30 Abbreviated New Drug Applications with the US Food and Drug Administration (FDA) to market generic drugs, despite regulatory issues for the US company.

© Copyright 2009